Given the key role of type I interferons in the initiation and perpetuation of autoimmunity in SLE, many efforts have been made to obtain an in-depth understanding of type I interferons and the development of targeted SLE therapies through intervening in IFN signaling pathways [9]. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.